SEARCH

SEARCH BY CITATION

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

FilenameFormatSizeDescription
eji2762-sup-0001-S1.pdf13966K

Figure S1. Serum cytokines and chemokines concentrations of ConA-injected mice treated with ADSCs.

Figure S2. Distribution of ADSCs in ConA-injected mice.

Figure S3. Analysis of gene expression in hepatic inflammatory cells of ConA-induced hepatitis mice with or without ADSC treatment.

Figure S4. Expression of cytokine/chemokine-related genes in ConA-stimulated hepatic inflammatory cells co-culture with ADSCs.

Figure S5. MDSC-related functional characteristics of hepatic inflammatory cells in ConA-hepatitis mice treated with or without ADSCs.

Table S1. Maps relevant to genes the expression of which was affected in the liver of ConA-injected mice, followed by immediate ADSC treatment.

Table S2. Pathway maps for genes the expression of which in hepatic inflammatory cells of ConAhepatitis mice was significantly affected by ADSC treatment.

Table S3. Networks for genes whose expression in the hepatic inflammatory cells of ConAhepatitis mice was significantly affected by ADSCs treatment.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.